BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel DN, Zhao HH, Houman J, Ackerman AL, Eilber KS, Anger JT. Comparative effectiveness of one versus two‐stage sacral neurostimulation device placement. Neurourology and Urodynamics 2019;38:734-9. [DOI: 10.1002/nau.23908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kocher NJ, Derisavifard S, Rueb J, Goldman HB. Predictive factors of PNE success in a contemporary series: A single institution experience. Neurourol Urodyn 2021;40:376-83. [PMID: 33205855 DOI: 10.1002/nau.24571] [Reference Citation Analysis]
2 Tay LJ, Harry D, Malde S, Sahai A. Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder. Urology 2021;149:1-10. [PMID: 33227305 DOI: 10.1016/j.urology.2020.11.018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Feldkamp A, Amasyalı AS, Groegler J, Jellison F, Staack A. Evaluation of progression from first to second stage sacral neuromodulation and unplanned device removal. Turk J Urol 2021;47:58-65. [PMID: 33112732 DOI: 10.5152/tud.2020.20288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]